Our in vivo, ex vivo and in vitro investigation showed that TRAF2 expression in the osteotropic MDA-231 human breast cancer cells increases tumour cell growth in bone, and enhances the ability of these cells to induce osteoclast formation and to cause osteolysis in mice. Here, TRAF2 is linked to breast carcinoma.